DaVita (DVA)
(Delayed Data from NYSE)
$138.48 USD
-1.89 (-1.35%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $138.46 -0.02 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, DaVita Inc. has a PEG ratio of 1.11 compared to the Medical - Outpatient and Home Healthcare industry's PEG ratio of 1.67.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DVA 138.48 -1.89(-1.35%)
Will DVA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DVA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DVA
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note
Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?
DVA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Chemed (CHE) Q2 Earnings Miss Estimates
DaVita HealthCare (DVA) Reports Next Week: Wall Street Expects Earnings Growth
Universal Health to Report Q2 Earnings: What Do the Key Estimates Say?
Other News for DVA
DaVita Inc (DVA) Partners with Food is Medicine Coalition to Address Chronic Illness and Food ...
Insider Sell Alert: James Hearty Sells Shares of DaVita Inc (DVA)
DaVita Breaks Above 200-Day Moving Average - Bullish for DVA
Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy)
DaVita Inc (DVA) Announces Second Quarter 2025 Investor Conference Call | DVA stock news